Research Paper Volume 16, Issue 12 pp 10446—10461
Notoginsenoside R1 (NGR1) regulates the AGE-RAGE signaling pathway by inhibiting RUNX2 expression to accelerate ferroptosis in breast cancer cells
Figure 2. RUNX2 may be a predictive target of NGR1 in breast cancer. (A) Expression of 11 intersecting genes was examined in the TCGA database of breast cancer patients. (B) NGR1 drug structural formula and relative molecular mass. (C) NGR1 molecular docking with RUNX2.